Related Experiment Video
Updated: Aug 7, 2026
16:49
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
[Coinfection with hepatitis C virus and HIV]
Th A Ruys1, H W Reesink, J M Lange
1Afd. Inwendige Geneeskunde, onderafd. Infectieziekten, Tropische Geneeskunde en Aids, Academisch Medisch Centrum/Universiteit van Amsterdam, Postbus 22.660, 1100 DD Amsterdam. t.ruys@amc.uva.nl
Nederlands Tijdschrift Voor Geneeskunde
|November 11, 2003
Summary
Highly active anti-retroviral therapy has improved HIV life expectancy, but hepatitis C virus (HCV) co-infection increases liver disease risk. Screening and considering HCV treatment are crucial for HIV patients.
Area of Science:
- Hepatology and Virology
- Infectious Diseases
- Immunology
Context:
- HIV life expectancy has significantly increased due to highly active anti-retroviral therapy (HAART).
- Retrospective studies indicate a rise in hospital admissions and mortality related to hepatitis C virus (HCV) co-infection among HIV patients.
- HIV-HCV co-infection accelerates liver disease progression, including cirrhosis and liver failure, compared to HCV monoinfection.
Purpose:
- To highlight the increased risk of severe liver complications in HIV patients co-infected with HCV.
- To emphasize the importance of screening all HIV-infected individuals for HCV.
- To discuss current and emerging treatment strategies for HIV-HCV co-infection.
Summary:
- HIV-HCV co-infected patients experience more rapid liver disease progression.
- Screening for HCV in HIV patients is recommended.
- Peginterferon and ribavirin are potential first-line treatments, but caution is advised with certain drug combinations. New antiviral agents show promise.
Impact:
- Early detection and management of HCV in HIV patients can mitigate liver disease progression.
- Improved understanding of HIV-HCV interactions guides clinical practice and therapeutic development.
- Potential for better patient outcomes and reduced mortality through targeted screening and treatment protocols.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...